UNSPSC 51283805: Virginiamycin

This classification denotes a depsipeptide antibiotic with the molecular formula C43H49N7O10, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier C49WS9N75L, more generally known as virginiamycin. European Medicines Agency schedules virginiamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05111MIG. The term VIRGINIAMYCIN is an International Non-Proprietary Name or INN. see World Health Organization INN reference publication, volume 22, no. 10, 1968, list 8.

VIRGINIAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51283805 Virginiamycin, a Commodity code, covers pharmaceutical active ingredients and specialty chemicals used in livestock and animal-health applications; however, the recent state and local opportunities tagged under this code do not reflect that scope. The Illinois Department of Public Health's piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium, awarded to Chartwell Rx LLC on August 28, 2026, supplied human-use antibiotics—Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets—valued at $2,999,999.11 over a three-year term. Seminole County, Florida issued an IFB on June 30, 2026 for Naloxone and Safe Drug Deactivation Systems for community health initiatives. Neither opportunity aligns with the Virginiamycin commodity definition. The issuing bodies include state health departments and county government agencies focused on emergency medical or public-health supply chains.

The code shows recent activity in Illinois and Florida, though the opportunities appear to be misclassified under Virginiamycin rather than reserved for that specific animal-health ingredient. The Illinois contract represents a statewide piggyback vehicle through a multistate consortium, while the Seminole County IFB was released with a July 26, 2023 response deadline (an historical record now closed). State and local procurement offices treating this code as a catch-all for pharmaceutical commodities beyond its intended scope create significant noise for vendors targeting animal-health or agricultural-feed-additive markets. Current activity in the code does not signal meaningful opportunity in the Virginiamycin market itself.